CLINICAL_TRIALS
research
· 2025-12-23
Clinical Trial Update: A Long-term Trial of EB-1020 in Pediatric Patients With ADHD [Phase 3]
Summary
A Phase 3 long-term clinical trial evaluating EB-1020 in pediatric patients with attention-deficit/hyperactivity disorder is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Attention-Deficit Hyperactivity Disorder(ADHD) | Phase 3 | Status: RECRUITING